-
Spark Therapeutics Announces Closing of Public Offering
Post on 6/21/16
-
Medgenics Announces Public Offering of Common Stock
Post on 6/21/16
-
Better Buy: Ziopharm Oncology, Inc. vs. Celgene
Post on 6/20/16
-
Better Buy: AbbVie Inc. vs. Johnson & Johnson
Post on 6/20/16
-
Digging Below the Surface: Here's What Celgene's New Stock Buyback Really Implies
Post on 6/20/16
-
InstaMed Releases Sixth Annual Trends in Healthcare Payments Report
Post on 6/17/16
-
Merck & Co., Inc. Wins This Round of the Immunotherapy Lung-Cancer Battle
Post on 6/17/16
-
AAC Holdings Commences Development of 150-Bed Treatment Center in New Jersey
Post on 6/16/16
-
Amneal Pharmaceuticals Honored with Best Overall Generics Manufacturer Award by Healthcare Distribution Alliance
Post on 6/16/16
-
Cyclacel Regains Compliance With Nasdaq Continued Listing Requirements
Post on 6/16/16
-
Better Buy: Johnson & Johnson vs. Eli Lilly
Post on 6/16/16
-
Champions Oncology Closes Stock Offering
Post on 6/15/16
-
Celgene Announces Additional $3 Billion Share Repurchase Authorization
Post on 6/15/16
-
3 Biotech Stocks to Buy If the Market Crashes
Post on 6/15/16
-
Should Pfizer Buy This Beaten-Down Immuno-Oncology Company?
Post on 6/15/16
-
Spark Therapeutics Announces Pricing of Public Offering
Post on 6/15/16
-
RCCA and Osler Health Join Forces to Provide Cancer Care using Collaborative Physician Teams
Post on 6/14/16
-
Spark Therapeutics Announces Launch of Public Offering
Post on 6/14/16
-
United Health Foundation Partnership with New Jersey Hospital Association
Post on 6/13/16
-
Celsion Corp. Announces $6 Million Offering
Post on 6/13/16
-
BioScrip Acquires Home Solutions
Post on 6/13/16
-
Johnson & Johnson: Can Anything Slow It Down?
Post on 6/13/16
-
Better Buy: GlaxoSmithKline vs. Pfizer
Post on 6/10/16
-
Why PTC Therapeutics Jumped 10% In May
Post on 6/10/16
-
Champions Oncology Prices Stock Offering
Post on 6/9/16
Philadelphia
